Zusduri Dosage
Generic name: Mitomycin 40mg;
Dosage form: kit
Drug class: Antibiotics / antineoplastics
Medically reviewed by Drugs.com. Last updated on Jun 20, 2025.
Important Administration Instructions
Administer ZUSDURI by intravesical instillation only. Do not administer by pyelocalyceal instillation or by any other route.
Recommended Dose
The recommended dose of ZUSDURI is 75 mg (56 mL) instilled once weekly for six weeks into the bladder via a urinary catheter.
Preparation Instructions
See the Instructions for Pharmacy enclosed in the carton for complete information on preparation.
ZUSDURI must be reconstituted with sterile hydrogel under chilled conditions. Reconstituted ZUSDURI has reverse thermal properties with a gelation point of approximately 19°C (66°F) and will appear as a viscous liquid under chilled conditions and a semisolid gel at room temperature.
Storage Instructions for Reconstituted ZUSDURI:
- Instill reconstituted ZUSDURI as soon as possible.
- If not used immediately, store reconstituted ZUSDURI:
- under refrigeration at 2℃ to 8℃ (36°F to 46°F) for up to 7 days; or
- under refrigeration at 2℃ to 8℃ (36°F to 46°F) for up to 6 days followed by no more than 24 hours at room temperature, 20°C to 25°C (68°F to 77°F).
- Discard 7 days after reconstitution.
- Protect from light.
- Avoid excessive heat over 40°C (104°F).
ZUSDURI is a hazardous drug. Follow applicable special handling and disposal procedures.1
Bladder Instillation of ZUSDURI
See the Instructions for Administration enclosed in the carton for complete information on bladder instillation.
ZUSDURI must be chilled at -3°C to 5°C (27°F to 41°F) to convert to a viscous liquid prior to instillation. When instilling ZUSDURI, each syringe must be emptied within thirty (30) seconds to avoid gelation.
Instillation of ZUSDURI requires syringes and a urinary catheter with fixed Luer Lock connectors.
Advise patients that ZUSDURI may discolor urine to a violet to blue color following the instillation procedure. Advise patients for at least 24 hours post-instillation to avoid urine contact with skin, to void urine sitting on a toilet, to wash hands and genital area with water and soap after each urination, and to flush the toilet several times after use.
More about Zusduri (mitomycin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (1)
- Side effects
- During pregnancy
- FDA approval history
- Drug class: antibiotics/antineoplastics
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Anktiva
Anktiva (N-803) is used to treat specific types of bladder cancer. It is FDA-approved to be used ...
Enfortumab vedotin
Enfortumab vedotin is used for bladder cancer, urothelial carcinoma
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.